Compare GameStop Corp. (GME) vs Nuwellis Inc (NUWE) Price & Performance

GME trades at $22.43, up 1.82% today, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.30 exceeding the $0.16 estimate. Revenue for 2025 was $3.82 billion, with net income of $131.3 million, marking a significant turnaround from prior losses. Recent news highlights a partnership with Uber Eats and a proposed eBay acquisition as strategic growth catalysts.

The outlook is mixed; fundamentals show improving profitability and a robust balance sheet with $4.77 billion cash, but revenue declines and competitive pressures from digital game distribution pose risks. Analyst sentiment is cautious with only 16.7% buy ratings. Key opportunities include EBITDA guidance exceeding $600 million for 2026, while execution risks around the eBay bid and industry shifts remain headwinds.

Nuwellis (NUWE) trades at $3.22, up 15% in the last 24 hours, following a recent 35:1 reverse stock split executed on June 26, 2026. The medical technology company shows a mixed financial picture with a strong gross margin of 65.47% but significant net losses and negative profitability ratios. Recent news highlights expansion in pediatric care, new patent awards, and a $6 million public offering closed in June 2026 to fund operations. Technical indicators are predominantly bearish, with moving averages signaling strong selling pressure.

The outlook remains challenging due to persistent operating losses and negative cash flow, offset by strategic pediatric market expansion and new product innovation. Investment opportunity hinges on the company's ability to translate its high gross margin and recent capital raise into sustainable revenue growth and eventual profitability. Key risks include continued cash burn, execution of commercial strategy, and reliance on financing activities to fund operations.